Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Mesenchymal Transition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02602938
What this trial is testing

Aspirin on CTCs of Advanced Breast and Colorectal Cancer

Who this might be right for
Epithelial-Mesenchymal TransitionCirculating Tumor Cells
Zhejiang Provincial People's Hospital 40
Not applicableUnknownNCT05995067
What this trial is testing

The Potential Association of Long Non-coding RNA (NEAT1 and MALAT1) in the Process of Epithelial-mesenchymal Transition in Periodontitis

Who this might be right for
Periodontal Disease, AVDC Stage 3and 4Epithelial Mesenchymal TransitionLong Noncoding RNA
Ali A Abdulkareem 48
Testing effectiveness (Phase 2)UnknownNCT05176665
What this trial is testing

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

Who this might be right for
NeoplasmsNeoplasm MetastasisMetastatic Gastrointestinal Carcinoid Tumor
Shanghai EpimAb Biotherapeutics Co., Ltd. 152
Post-approval studies (Phase 4)Study completedNCT05110196
What this trial is testing

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

Who this might be right for
Non-Small Cell Lung Carcinoma
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Ended earlyNCT03138083
What this trial is testing

OMO-1 in Solid Malignancies

Who this might be right for
Neoplasms
Octimet Oncology N.V. 40
Testing effectiveness (Phase 2)UnknownNCT03797391
What this trial is testing

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

Who this might be right for
NeoplasmsNeoplasm MetastasisNon-Small-Cell Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd. 186
Testing effectiveness (Phase 2)WithdrawnNCT03147976
What this trial is testing

QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
NantPharma, LLC
Not applicableStudy completedNCT02579460
What this trial is testing

Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition

Who this might be right for
Barrett's EsophagusGastroesophageal Reflux Disease
Dallas VA Medical Center 15
Early research (Phase 1)Looking for participantsNCT07181681
What this trial is testing

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Solid Tumor
BeOne Medicines 63
Early research (Phase 1)Study completedNCT03258515
What this trial is testing

Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers

Who this might be right for
Solid Tumors
AstraZeneca 45
Not applicableLooking for participantsNCT07286916
What this trial is testing

Impact of Guided Biofilm Therapy on Epithelial and Mesenchymal Biomarkers in Periodontitis Patients

Who this might be right for
Periodontitis
University of Baghdad 18
Testing effectiveness (Phase 2)Study completedNCT02544633
What this trial is testing

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Who this might be right for
Non-Small Cell Lung Cancer
Mirati Therapeutics Inc. 68
Testing effectiveness (Phase 2)Looking for participantsNCT05550415
What this trial is testing

The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer

Who this might be right for
Triple Negative Breast CancerChemotherapy EffectSimvastatin Adverse Reaction
Universitas Indonesia 26
Large-scale testing (Phase 3)Ended earlyNCT01697072
What this trial is testing

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric Cancer
Amgen 609
Testing effectiveness (Phase 2)Looking for participantsNCT05541822
What this trial is testing

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation

Who this might be right for
Advanced Solid Tumors
Abion Inc 178
Testing effectiveness (Phase 2)Looking for participantsNCT06669117
What this trial is testing

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

Who this might be right for
Solid TumorMET Alteration
Pierre Fabre Medicament 140
Not applicableUnknownNCT03462953
What this trial is testing

Identification of EMT Indicators in Healthy and Periodontally Diseased Gingival Samples

Who this might be right for
Chronic Periodontitis
Cairo University 36
Post-approval studies (Phase 4)UnknownNCT01111422
What this trial is testing

Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients

Who this might be right for
End-Stage Kidney DiseasePeritoneal Dialysis
Ewha Womans University 66
Not applicableStudy completedNCT03458819
What this trial is testing

EMT in Peritoneal Dialysis Patients

Who this might be right for
Peritoneal Dialysis Complication
University of Colorado, Denver 22
Early research (Phase 1)Ended earlyNCT04982224
What this trial is testing

Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer

Who this might be right for
Advanced NSCLC
Regeneron Pharmaceuticals 30
Next Page